October 9, 2008.
Alternative Medicine Pioneer and Author, Nancy Lonsdorf, MD, Helps Launch New Prescription Drug Ratings Website.
RateADrug.com is pleased to announce that Nancy Lonsdorf, MD has joined its Scientific Board of Advisors.
Dr. Lonsdorf is a leading expert in Ayurvedic Medicine and other alternative approaches to health care and herbal prevention therapies. She has been named by the Chicago Tribune as "one of the nation's most prominent Ayurvedic doctors."
Dr. Lonsdorf received her Medical Degree from Johns Hopkins School of Medicine and her residency training in psychiatry at Stanford University. She is the author of A Woman's Best Medicine and The Ageless Woman: Natural Health and Beauty After Forty. Dr. Lonsdorf lectures extensively about issues regarding both Western and Eastern approaches to health care.
"We are delighted to have Dr. Lonsdorf join RateADrug.com," says Mark Deuitch, RateADrug.com founder and CEO. Our goal has been to attract the smartest people from all sectors of health care, including scientists, clinicians, MD's, and alternative practitioners like Dr. Lonsdorf.
"Dr. Lonsdorf's scientific expertise in medical ethics, alternative and holistic medications, and conventional prescription drug treatments will help RateADrug.com achieve its goal of creating the world's largest database of unbiased user generated information about prescription drugs and other medical therapies," Deuitch continues.
"Health care is changing and will continue to change dramatically, whether the John McCain or the Barack Obama health care plans get implemented," Deuitch adds. "The one constant in health care is the need for greater creativity, discovery, and transparency in dealing with the effectiveness and potential negative side effects of prescription drugs and other medical treatments."
Deuitch says, "RateADrug.com's technology uses the web to provide innovative large scale user generated information to help identify long term occurrences of positive and adverse reactions in medical treatments. Our goal is to allow users to compare different treatments for common illnesses effectively on the basis of post clinical trial experiences and data from actual users."
About RateADrug.com:
RateADrug.com develops and maintains information technologies for users of prescription drugs and other therapies. The site http://www.rateadrug.com allows users to view and rate experiences on over 3,000 prescription drugs including Lipitor, Plavix, Viagra, Lexapro, Zoloft, Cialis, Vytorin, Provigil, Yasmin, Meridia, and other popular brands. Its information is collected from a highly diverse population of prescription drug end-users. RateADrug.com does not accept advertising from pharmaceutical companies.
Mr. Deuitch is also the founder of http://www.fastdue.com, a web based suite of online productivity and cost management tools for professionals and small businesses.
May 30, 2008. High Profile CEO Carl Singer Joins Iowa Internet Startup RateADrug.com.
RateADrug.com, a new community-driven medical information website, today announced
that noted business leader Carl Singer has joined its board of directors as non-executive
Chairman.
Mr. Singer has served on 31 boards of directors and as CEO or President of leading
companies including Sealy, BVD Company, Scripto, Microdyne, Renfield, Viragen and
Timberland Industries. He is currently CEO and Chairman of Fundamental Asset Management,
and a director of YourFreeLegalForms.com and FastDue.com.
"In addition to running some of America's most successful consumer companies, Carl
Singer brings to RateADrug unique management experience in biotechnology clinical
trials and in drug safety, efficacy and regulatory issues. We look forward to his
hands-on participation," said RateADrug President Mark Deuitch.
Mr. Singer has served as a Board of Trustee member at Emory
University in Atlanta, Georgia and is an active member of the Friends
for Life at the University of Miami and the
Renaissance Group of Dartmouth-Hitchcock Medical Center in New Hampshire. He has
been recognized for his philanthropy by the Center for Medical Education at the
University of Miami. He has been awarded the
honorary degree of Doctor of Commerce by the Huizenga School of Business and Entrepreneurship
at Nova Southeastern University in Ft. Lauderdale,
FL.
Mr. Singer will assist RateADrug in establishing an alternative and more interactive
class of patient-generated health information to complement traditional sources
of health data such as FDA, NIH, and Mayo Clinic research and pharmaceutical warning
labels disclosures.
About RateADrug.com:
RateADrug.com provides an online, community-based rating system that allows users
to share information about possible side effects and benefits they experience from
prescription drugs, medical procedures and nutritional supplements. The site uses
anecdotal reports from highly diversified user groups to add to data from clinical
trials and FDA disclosures. Users can evaluate and share their experiences about
a broad range of medical treatments, alternative therapies and prescription drugs
by participating in RateADrug's ongoing surveys.
RateADrug is currently conducting specific large-group studies for the following
classes of drugs: cholesterol-lowering statin drugs Lipitor, Lescol, Mevacor, Pravachol,
and Zocar; anti-depressants Lexapro, Prozac, Effexor, Paxil, Zoloft, and Pristiq,
and insomnia treatments Ambien, Lunesta, Sonata, Rozerem, and Benzodiazepines. Users
can currently review or submit ratings on over one thousand different medications
at http://RateAdrug.com.